Article Versions Notes

Ticinesi A, Tuttolomondo D, Nouvenne A, Parise A, Cerundolo N, Prati B, Zanichelli I, Guerra A, Gaibazzi N, Meschi T. Co-Administration of Remdesivir and Azithromycin May Protect against Intensive Care Unit Admission in COVID-19 Pneumonia Requiring Hospitalization: A Real-Life Observational Study. Antibiotics. 2022; 11(7):941. https://doi.org/10.3390/antibiotics11070941

Ticinesi, Andrea, Domenico Tuttolomondo, Antonio Nouvenne, Alberto Parise, Nicoletta Cerundolo, Beatrice Prati, Ilaria Zanichelli, Angela Guerra, Nicola Gaibazzi, and Tiziana Meschi. 2022. "Co-Administration of Remdesivir and Azithromycin May Protect against Intensive Care Unit Admission in COVID-19 Pneumonia Requiring Hospitalization: A Real-Life Observational Study" Antibiotics 11, no. 7: 941. https://doi.org/10.3390/antibiotics11070941

Ticinesi, A., Tuttolomondo, D., Nouvenne, A., Parise, A., Cerundolo, N., Prati, B., Zanichelli, I., Guerra, A., Gaibazzi, N., & Meschi, T. (2022). Co-Administration of Remdesivir and Azithromycin May Protect against Intensive Care Unit Admission in COVID-19 Pneumonia Requiring Hospitalization: A Real-Life Observational Study. Antibiotics, 11(7), 941. https://doi.org/10.3390/antibiotics11070941